<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1308.html">Part 1308
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1308.26  Excluded veterinary anabolic steroid implant products.
                            </h3>
                            <p class="depth1"><em>(a)</em> Products containing an anabolic steroid, that are expressly  intended for administration through implants to cattle or other nonhuman  species and which have been approved by the Secretary of Health and  Human Services for such administration are excluded from all schedules  pursuant to section 102(41)(B)(i) of the Act (21 U.S.C. 802(41)(B)(i)).  A listing of the excluded products may be obtained by submitting a  written request to the Drug and Chemical Evaluation Section, Drug  Enforcement Administration. See the Table of DEA Mailing Addresses in  Sec. 1321.01 of this chapter for the current mailing address.</p><p class="depth1"><em>(b)</em> In accordance with section 102(41)(B)(ii) of the Act (21 U.S.C.  802(41)(B)(ii)) if any person prescribes, dispenses, or distributes a  product listed in paragraph (a) of this section for human use, such  person shall be considered to have prescribed, dispensed, or distributed  an anabolic steroid within the meaning of section 102(41)(A) of the Act  (21 U.S.C. 802(41)(A)).  [56 FR 42936, Aug. 30, 1991, as amended at 57 FR 19534, May 7, 1992; 58  FR 15088, Mar. 19, 1993; 62 FR 13967, Mar. 24, 1997; 75 FR 10679, Mar.  9, 2010]</p><p class="depth2">Exempted Prescription Products</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
